Literature DB >> 27475862

Roles of NTE protein and encoding gene in development and neurodevelopmental toxicity.

Miguel A Sogorb1, David Pamies2, Carmen Estevan3, Jorge Estévez4, Eugenio Vilanova4.   

Abstract

Neuropathy Target Esterase (NTE) is a membrane protein codified by gene PNPLA6. NTE was initially discovered as a target of the so-called organophosphorus-induced delayed polyneuropathy triggered by the inhibition of the NTE-associated esterase center by neuropathic organophosphorus compounds (OPs). The physiological role of NTE might be related to membrane lipid homeostasis and seems to be involved in adult organisms in maintaining nervous system integrity. However, NTE is also involved in cell differentiation and embryonic development. NTE is expressed in embryonic and adult stem cells, and the silencing of Pnpla6 by interference RNA in D3 mouse cells causes significant alterations in several genetic pathways related to respiratory tube and nervous system formation, and in vasculogenesis and angiogenesis. The silencing of gene PNPLA6 in human NT2 cells at the beginning of neurodifferentiation causes severe phenotypic alterations in neuron-like differentiated cells; e.g. reduced electrical activity and the virtual disappearance of markers of neural tissue, synapsis and glia. These phenotypic effects were not reproduced when NTE esterase activity was inhibited by neuropathic OP mipafox instead of being silenced at the genetic level. Neuropathic OP chlorpyrifos seems able to induce neurodevelopmental alterations in animals. However, the effects of chlorpyrifos in the expression of biomarker genes of differentiation in D3 cells differ considerably from the effects induced by Pnpla6 silencing. In conclusion, available information suggests that PNPLA6 and/or the NTE protein play a role in early neurodifferentiation stages, although this role is not dependent upon the esterase NTE center. Therefore, impairments caused by OPs, such as chlorpyrifos, on neurodevelopment are not due to inhibition of NTE esterase enzymatic activity. Copyright Â
© 2016 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Chlorpyrifos; Developmental toxicity; Differentiation; Neuropathy target esterase; Pnpla6; Stem cells

Mesh:

Substances:

Year:  2016        PMID: 27475862     DOI: 10.1016/j.cbi.2016.07.030

Source DB:  PubMed          Journal:  Chem Biol Interact        ISSN: 0009-2797            Impact factor:   5.192


  9 in total

1.  A novel PNPLA6 mutation in a Turkish family with intractable Holmes tremor and spastic ataxia.

Authors:  Ahmed S Emekli; Bedia Samanci; Gülşah Şimşir; Hasmet A Hanagasi; Hakan Gürvit; Başar Bilgiç; A Nazlı Başak
Journal:  Neurol Sci       Date:  2020-11-18       Impact factor: 3.307

2.  Identification of Novel Compound Heterozygous Variants of the PNPLA6 Gene in Boucher-Neuhäuser Syndrome.

Authors:  Junyu He; Xin Liu; Liyi Liu; Shaohao Zeng; Shuanghong Shan; Zhihong Liao
Journal:  Front Genet       Date:  2022-02-07       Impact factor: 4.599

Review 3.  PNPLA6/NTE, an Evolutionary Conserved Phospholipase Linked to a Group of Complex Human Diseases.

Authors:  Doris Kretzschmar
Journal:  Metabolites       Date:  2022-03-24

4.  DNA Methylation of Patatin-Like Phospholipase Domain-Containing Protein 6 Gene Contributes to the Risk of Intracranial Aneurysm in Males.

Authors:  Shengjun Zhou; Junjun Zhang; Chenhui Zhou; Fanyong Gong; Xueli Zhu; Xingqiang Pan; Jie Sun; Xiang Gao; Yi Huang
Journal:  Front Aging Neurosci       Date:  2022-07-11       Impact factor: 5.702

5.  Neuropathy target esterase (NTE/PNPLA6) and organophosphorus compound-induced delayed neurotoxicity (OPIDN).

Authors:  Rudy J Richardson; John K Fink; Paul Glynn; Robert B Hufnagel; Galina F Makhaeva; Sanjeeva J Wijeyesakere
Journal:  Adv Neurotoxicol       Date:  2020-03-03

6.  Novel variants in PNPLA6 causing syndromic retinal dystrophy.

Authors:  Shijing Wu; Zixi Sun; Tian Zhu; Richard G Weleber; Paul Yang; Xing Wei; Mark E Pennesi; Ruifang Sui
Journal:  Exp Eye Res       Date:  2020-10-22       Impact factor: 3.467

7.  Analysis of the neurotoxic effects of neuropathic organophosphorus compounds in adult zebrafish.

Authors:  Melissa Faria; Inmaculada Fuertes; Eva Prats; Jose Luis Abad; Francesc Padrós; Cristian Gomez-Canela; Josefina Casas; Jorge Estevez; Eugenio Vilanova; Benjamin Piña; Demetrio Raldúa
Journal:  Sci Rep       Date:  2018-03-19       Impact factor: 4.379

8.  A novel PNPLA6 compound heterozygous mutation identified in a Chinese patient with Boucher‑Neuhäuser syndrome.

Authors:  Ruizhi Zheng; Yaguang Zhao; Jiayu Wu; Yuanmei Wang; Jian-Ling Liu; Zhi-Ling Zhou; Xiao-Tao Zhou; Dan-Na Chen; Wei-Hua Liao; Jia-Da Li
Journal:  Mol Med Rep       Date:  2018-05-03       Impact factor: 2.952

9.  Neurite outgrowth inhibitory levels of organophosphates induce tissue transglutaminase activity in differentiating N2a cells: evidence for covalent adduct formation.

Authors:  Ibtesam S Almami; Maha A Aldubayan; Shatha G Felemban; Najiah Alyamani; Richard Howden; Alexander J Robinson; Tom D Z Pearson; David Boocock; Alanood S Algarni; A Christopher Garner; Martin Griffin; Philip L R Bonner; Alan J Hargreaves
Journal:  Arch Toxicol       Date:  2020-08-04       Impact factor: 6.168

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.